Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming
Joshua D. Bernstock(National Institutes of Health), John M. Hallenbeck(National Institutes of Health)
Cited by 41
Related Papers
Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke.
|Stroke|1992|620
SUMOylation promotes survival and integration of neural stem cell grafts in ischemic stroke
|EBioMedicine|2019|56
Integrative transcriptomic and metabolic analyses of the mammalian hibernating brain identifies a key role for succinate dehydrogenase in ischemic tolerance
|bioRxiv (Cold Spring Harbor Laboratory)|2023|6